Evidence map›Paper›PMID 23740900›Full record

ArticleScience translational medicine2013

Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease.

Gerald P Morris, Geoffrey L Uy, David Donermeyer, John F Dipersio, Paul M Allen

Abstract read
In one paragraph

Article in Science translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. TCRα reporter mice reveal contribution of dual TCRα expression to T cell repertoire and function.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Article
  9. Dual TCR T Cells: Identity Crisis or Multitaskers?Journal of immunology (Baltimore, Md. : 1950) · 2019
    Review
  10. Review
  11. MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Article
  13. Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2017
    Article
  14. Article
  15. Alloimmune T cells in transplantation.The Journal of clinical investigation · 2017
    Review
  16. Review
  17. Review
  18. Article
  19. Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Article
  20. The highly alloreactive nature of dual TCR T cells.Current opinion in organ transplantation · 2016
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gerald P MorrisDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA. pallen@wustl.edu
Geoffrey L Uy
David Donermeyer
John F Dipersio
Paul M Allen
Washington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
RECOGNITION AND SIGNALING IN POSITIVE SELECTION OF CD4+ T CELLSR01AI024157 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 1987 to 2016
$2.5M
T Cell Recognition of Allogeneic Peptide/MHC LigandsR01AI061173 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 2005 to 2009
$1.8M
Targeting Leukemia Stromal Interactions in AMLK23CA140707 · NCI · WASHINGTON UNIVERSITY · PI UY, GEOFFREY L · 2009 to 2013
$793k
Investigation of the Molecular Basis of T Cell AlloreactivityK08AI085039 · NIAID · WASHINGTON UNIVERSITY · PI MORRIS, GERALD PATRICK · 2010 to 2014
$531k
NCATS NIH HHS UL1 TR000448NCI NIH HHS K23 CA140707NCI NIH HHS K23CA140707NCI NIH HHS P30 CA091842NCI NIH HHS P30CA91842NCRR NIH HHS UL1 RR024992NIAID NIH HHS K08 AI085039NIAID NIH HHS K08AI085039NIAID NIH HHS R01 AI024157NIAID NIH HHS R01 AI061173NIAID NIH HHS R01AI061173
6 · The paper itself

Abstract

Acute graft-versus-host disease (aGVHD) results from a robust response of donor T cells transferred during hematopoietic stem cell transplantation (HSCT) to allogeneic peptide-major histocompatibility complex antigens. Previous investigations have not identified T cell subsets that selectively mediate either protective immunity or pathogenic alloreactivity. We demonstrate that the small subset of peripheral T cells that naturally express two T cell receptors (TCRs) on the cell surface contributes disproportionately to aGVHD in patients after allogeneic HSCT. Dual TCR T cells from patients with aGVHD demonstrate an activated phenotype and produce pathogenic cytokines ex vivo. Dual receptor clones from a patient with symptomatic aGVHD responded specifically to mismatched recipient human leukocyte antigens (HLAs), demonstrating pathologic alloreactivity. Human dual TCR T cells are strongly activated and expanded by allogeneic stimulation in vitro, and disproportionately contribute to the repertoire of T cells recognizing both major (HLA) and minor histocompatibility antigens, providing a mechanism for their observed activity in vivo in patients with aGVHD. These results identify dual TCR T cells as a target for focused analysis of a T cell subset mediating GVHD and as a potential prognostic indicator.

Indexed as

Acute DiseaseAntibodies, MonoclonalCytokinesFlow CytometryGraft vs Host DiseaseHLA AntigensHumansLymphocyte ActivationReceptors, Antigen, T-CellT-LymphocytesAntibodies, MonoclonalCytokinesHLA AntigensReceptors, Antigen, T-Cell

Identifiers

PMID23740900
PMCPMC3859344
OpenAlexW2103668327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.